前列腺癌调强放疗与长期泌尿生殖系统毒性：不断演变的治疗格局 - Suppr

Suppr

超能文献

Prostate cancer intensity-modulated radiotherapy and long term genitourinary toxicity: an evolving therapeutic landscape.

作者信息

Achard Vérane, Zilli Thomas

机构信息

Department of Radiation Oncology, Geneva University Hospital, Geneva, and Faculty of Medicine, Geneva, Switzerland.

出版信息

Prostate Cancer Prostatic Dis. 2023 Mar;26(1):1-2. doi: 10.1038/s41391-022-00535-4. Epub 2022 Apr 29.

DOI:10.1038/s41391-022-00535-4

PMID:35488121

Abstract

摘要

相似文献

Prostate cancer intensity-modulated radiotherapy and long term genitourinary toxicity: an evolving therapeutic landscape.前列腺癌调强放疗与长期泌尿生殖系统毒性：不断演变的治疗格局

Prostate Cancer Prostatic Dis. 2023 Mar;26(1):1-2. doi: 10.1038/s41391-022-00535-4. Epub 2022 Apr 29.

Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer.接受调强放射治疗的局限性前列腺癌患者的疗效和毒性。

J Urol. 2013 Aug;190(2):521-6. doi: 10.1016/j.juro.2013.02.012. Epub 2013 Feb 13.

The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy.预处理前列腺体积对接受调强放疗的前列腺癌患者严重急性泌尿生殖系统毒性的影响。

Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):379-84. doi: 10.1016/j.ijrobp.2009.11.023. Epub 2010 May 6.

Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.调强放射治疗作为前列腺癌的主要治疗方法：关于对前列腺内病变进行同步整合加量剂量递增后的急性毒性报告。

Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):799-807. doi: 10.1016/j.ijrobp.2008.01.040. Epub 2008 Apr 11.

High-dose intensity-modulated radiation therapy as primary treatment of prostate cancer: genitourinary/gastrointestinal toxicity and outcomes, a single-institution experience.高剂量强度调制放疗作为前列腺癌的主要治疗方法：单机构经验的泌尿生殖/胃肠道毒性和结局。

Radiol Med. 2019 May;124(5):422-431. doi: 10.1007/s11547-018-0977-1. Epub 2019 Jan 3.

Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.大分割调强弧形放疗用于淋巴结转移的前列腺癌

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1013-20. doi: 10.1016/j.ijrobp.2008.12.047. Epub 2009 Apr 20.

Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results.每周接受4次或5次治疗的高危前列腺癌患者的图像引导调强分割放疗：毒性分析及初步结果

Radiat Oncol. 2014 Sep 26;9:214. doi: 10.1186/1748-717X-9-214.

Hypofractionated intensity-modulated simultaneous integrated boost and image-guided radiotherapy in the treatment of high-risk prostate cancer patients: a preliminary report on acute toxicity.大分割调强同步整合加量及图像引导放射治疗高危前列腺癌患者：急性毒性的初步报告

Tumori. 2013 Jul-Aug;99(4):474-9. doi: 10.1177/030089161309900406.

Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.使用调强放射治疗、三维适形放射治疗、永久性植入近距离放射治疗和高剂量率近距离放射治疗对前列腺癌放疗的急性和亚急性泌尿生殖系统及胃肠道不良事件进行比较。

Tumori. 2014 May-Jun;100(3):265-71. doi: 10.1700/1578.17198.

Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: a preliminary report of disease control.高危前列腺癌患者的调强盆腔放射治疗及前列腺区域同步整合加量：疾病控制的初步报告

Cancer Med. 2014 Oct;3(5):1313-21. doi: 10.1002/cam4.278. Epub 2014 Jun 28.

引用本文的文献

Exploring the dosimetric advantages of a novel multi-modality radiotherapy platform in prostate cancer.探索一种新型多模态放射治疗平台在前列腺癌治疗中的剂量学优势。

Phys Eng Sci Med. 2025 May 12. doi: 10.1007/s13246-025-01544-y.

Impact of bladder volume and bladder shape on radiotherapy consistency and treatment interruption in prostate cancer patients.膀胱容量和膀胱形状对前列腺癌患者放射治疗一致性及治疗中断的影响

J Appl Clin Med Phys. 2025 Apr;26(4):e70026. doi: 10.1002/acm2.70026. Epub 2025 Feb 19.

Focal therapy of prostate cancer: Use of artificial intelligence to define tumour volume and predict treatment outcomes.前列腺癌的聚焦治疗：利用人工智能确定肿瘤体积并预测治疗结果。

BJUI Compass. 2024 Nov 28;6(1):e456. doi: 10.1002/bco2.456. eCollection 2025 Jan.

Review of Current Treatment Intensification Strategies for Prostate Cancer Patients.前列腺癌患者当前治疗强化策略综述

Cancers (Basel). 2023 Nov 28;15(23):5615. doi: 10.3390/cancers15235615.

本文引用的文献

Radiation Dose to the Intraprostatic Urethra Correlates Strongly With Urinary Toxicity After Prostate Stereotactic Body Radiation Therapy: A Combined Analysis of 23 Prospective Clinical Trials.前列腺立体定向体部放射治疗后，前列腺内尿道的辐射剂量与尿毒性密切相关：23 项前瞻性临床试验的联合分析。

Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):75-82. doi: 10.1016/j.ijrobp.2021.06.037. Epub 2021 Oct 25.

Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016).Hypofractionated 放疗对前列腺癌患者报告结局的影响：CHHiP 试验（CRUK/06/016）5 年随访结果。

Eur Urol Oncol. 2021 Dec;4(6):980-992. doi: 10.1016/j.euo.2021.07.005. Epub 2021 Sep 3.

Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results.每周一次或每两天一次的尿道保留前列腺癌立体定向体放射治疗：一项随机 II 期试验：18 个月随访结果。

Cancer Med. 2020 May;9(9):3097-3106. doi: 10.1002/cam4.2966. Epub 2020 Mar 11.

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.一项在常规或低分割高剂量强度调制放疗治疗前列腺癌的 3 期试验中进行的图像引导放疗随机评估。

Radiother Oncol. 2020 Jan;142:62-71. doi: 10.1016/j.radonc.2019.10.017. Epub 2019 Nov 22.

Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.每日与每周前列腺癌图像引导放射治疗比较：3 期多中心随机试验。

Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1420-1429. doi: 10.1016/j.ijrobp.2018.07.2006. Epub 2018 Jul 31.

National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer.一项基于全国人口的研究，比较接受调强放疗与三维适形根治性放疗的前列腺癌男性患者的治疗相关毒性。

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1253-1260. doi: 10.1016/j.ijrobp.2017.07.040. Epub 2017 Sep 1.

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.随机分组试验：一种低分割辐射方案治疗局限性前列腺癌。

J Clin Oncol. 2017 Jun 10;35(17):1884-1890. doi: 10.1200/JCO.2016.71.7397. Epub 2017 Mar 15.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.常规分割与大分割高剂量调强放疗治疗前列腺癌：随机、非劣效性3期CHHiP试验的5年结果

Lancet Oncol. 2016 Aug;17(8):1047-1060. doi: 10.1016/S1470-2045(16)30102-4. Epub 2016 Jun 20.

Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer.高剂量强度调制放疗局部前列腺癌后三角区膀胱剂量对长期尿功能的影响。

Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):339-44. doi: 10.1016/j.ijrobp.2013.10.042.

Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre.澳大利亚单中心研究：74Gy 剂量递增调强放疗治疗局限性前列腺癌的毒性和长期结果。

Cancers (Basel). 2011 Sep 1;3(3):3419-31. doi: 10.3390/cancers3033419.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验